Abstract
Background:In recent years, sodium-glucose cotransporter 2 (sGLT2) inhibitors, a new treatment for diabetes mellitus (DM), are associated with an increased risk of urinary tract infections, particularly in older patients and...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
